September 2, 2014

Glaxo to Stop Paying Doctors for Drug Promotion

pin it button Glaxo to Stop Paying Doctors for Drug Promotion

promote drugs Glaxo to Stop Paying Doctors for Drug Promotion

Glaxo Says It Will Stop Paying Doctors to Promote Drugs

By Dr. Mercola

It is entirely legal for drug companies to pay medical professionals to promote their products, and this practice is widespread in the drug industry.

After all, as the New York Times reported, “doctors are most likely to value the advice of trusted peers,” which is why drug companies are known to invest heavily in paying physicians to speak about their products to other physicians (often at medical conferences).

The conflict of interest within this practice is obvious, which is why the drug industry often keeps quiet on their actual payments, as do the medical professionals involved. Now, in a first for any major drug company, British drug maker GlaxoSmithKline has announced that it is putting an end to this and other dubious business practices.

Glaxo to Stop Paying Doctors for Drug Promotion

Last month, Glaxo’s chief executive Andrew Witty announced the company would no longer pay health care professionals to promote its products or the diseases they treat to “audiences who can prescribe or influence prescribing.” Also set to be discontinued is the practice of paying for doctors to attend medical conferences (a practice that is already banned in the US but is still allowed in other countries).

Glaxo also plans to stop compensating its sales representatives based on the number of prescriptions that doctors write, instead saying that they will base their pay on technical knowledge, quality of service they provide and other factors.

This move was actually required as part of a corporate integrity agreement Glaxo made with the US Justice Department in 2011, but it only applies to the US. Glaxo now plans to extend the policy globally.

The new plan, which is expected to take effect worldwide by 2016, is said to be the culmination of a yearlong effort “to try and make sure we stay in step with how the world is changing,” according to Witty. But some believe it may simply be “a desperate attempt to deflect attention from recent scandals” that have plagued the drug giant…

Glaxo Paid the Largest Health Fraud Settlement in US History

In 2012, GlaxoSmithKline (GSK) plead guilty in the largest health fraud settlement in US history. The company was fined $3 billion to resolve criminal and civil liability charges related to illegal drug marketing and withholding information about health hazards associated with its diabetes drug Avandia and others, including Paxil and Wellbutrin. According to the US Justice Department, GlaxoSmithKline:

1. Unlawfully marketed the antidepressant Paxil to children and adolescents.

The drug is FDA approved for the treatment of depression in adults only. The complaint details how GSK manipulated the findings of one of these studies to reach the false conclusion that Paxil was effective against depression in adolescents.

A GSK employee also recommended revising a section of the study relating to side effects, removing the finding that serious side effects like worsening depression and hostility (suffered by 11 children in the study) were considered related to the treatment, and replacing it with a statement that headache (suffered by one participant) was the only side effect considered to be treatment-related.

The complaint calls the study, published in July 2001 in The Journal of American Academy of Child and Adolescent Psychiatry, “false and misleading.” This fraudulent and misleading study was subsequently used by GSK to illegally promote Paxil for children and teens…

2. Unlawfully marketed the antidepressant Wellbutrin for weight loss and sexual dysfunction.

In a NPR radio interview, Carmen Ortiz, U.S. Attorney for the District of Massachusetts, stated that “GSK hired a public relations firm to create a buzz about getting skinny and how you could have more sex simply by using this drug… using every imaginable form of high-priced entertainment, from Hawaiian vacations to paying doctors millions of dollars to go on speaking tours, to a European pheasant hunt, to tickets for Madonna concerts.”

One of the most high-profile accounts involved television celebrity Dr. Drew, who reportedly received $275,000 from GSK to promote Wellbutrin to treat sexual dysfunction associated with depression even though it hasn’t been proven effective for this purpose.

3. From 2001 through September 2007, failed to report safety data relating to clinical experience and other information as required by law to the FDA for the diabetes drug Avandia.

As previously reported, Avandia has been found to be profoundly dangerous—a fact hidden by GSK for over 10 years, as they knew it would adversely affect sales. This was revealed in a Senate Finance Committee report, released by Max Baucus and Charles E. Grassley in February 2010. The report also asked why the FDA allowed a clinical trial of Avandia to continue even after the agency estimated the drug had caused an estimated 83,000 heart attacks between 1999 and 2007.

GlaxoSmithKline Is Embroiled in Alleged Kickback Allegations in China

In 2012, China’s pharmaceutical market grew by 20 percent, a hefty increase now believed to be at least partly the result of years’ worth of bribery and scandal. GlaxoSmithKline, in particular, has faced above-average growth in the region, with its stock outperforming its competitor’s nearly 2 to 1 in 2012.

The company’s super growth appears to be backed by illegal marketing strategies, which actually encourage bribery. Allegations have been made, in fact, that GSK paid kickbacks to doctors, hospitals, and government officials, using travel agencies as middlemen to carry out the illegal acts. Doctors and government officials reportedly received perks such as travel, cash and even sexual favors that, when combined, amounted to nearly $5 billion, according to some reports.

Four Chinese GSK executives have been detained and accused of bribe collaboration so far in the six-month long investigation. British national Mark Reilly, GSK’s head of Chinese operations, reportedly left China in June 2013. Like most other drug companies,

GSK is no stranger to criminal allegations and convictions. So their recent announcement that they are ending two of the most controversial practices common to the drug industry does raise some eyebrows. Is this leopard really changing its spots… or are other motives at play?

Obviously, with their reputation increasingly tarnished by their 2012 $3-billion settlement and the ongoing bribery investigation in China, they could use all the positive PR they can get. As reported by Forbes, GSK may be simply doing some damage control, betting that what they lose in doctor drug promotions they’ll regain by bolstering their ailing reputation.

“…studies have shown that a company’s value as measured by market capitalization increases when its reputation is enhanced and that non-financial indicia of reputation are critically important tools that support the ability to charge premium prices and ensure access to capital markets. So it’s not a bad thing, or even necessarily financially disadvantageous, for executives to think broadly about societal benefit when managing corporations…”

Huge Fines Are Not Enough to Deter Drug Companies from Breaking the Law

After GSK paid its “dues” in the form of a $3-billion settlement and has followed through with its corporate integrity agreement to stop compensating its sales force based on doctors’ numbers of written prescriptions, it might appear that they are now changing their tune, straightening up and flying right.

But as a new observation piece published in the British Medical Journal points out, even with escalating criminal and civil penalties, international drug companies are not being deterred from breaking the law. Even after paying enormous fines and being monitored under mandated corporate integrity agreements, many drug companies go on to commit additional criminal acts. The review goes so far as to state that “commission of such criminal and civil violations has become part of their business models.”

“Are criminal and civil penalties of hundreds of millions of dollars an important deterrent to law breaking by international drug companies? Further, would external monitoring in the form of US government mandated corporate integrity agreements (CIA) to prevent recurrences of such illegal activities, lasting five years after being signed, be an additional deterrent? Yes in both cases, but only if the size of the penalties outweighed the companies’ gains while violating the laws and only if enforcement of the CIAs were effective.

Unfortunately, neither is the case. This evaluation is based on the recent, sharp escalation in the frequency with which many giant multinational drug companies repeatedly engage in illegal criminal and civil activity after previously paying enormous fines and despite monitoring under CIAs. It seems that for some companies, commission of such criminal and civil violations has become part of their business models.”

Are You Wondering What Your Doctor Has Been Paid?

Beginning in 2014, you will be able to determine if a health care provider you trust is actually on the drug industry’s payroll, thanks to a new federal law that entails the following:

  • Drug and medical device companies will be required to report and disclose all payments (including stock options, research grants, knickknacks, consulting fees, travel expenses, and more) to physicians. Unfortunately, payments to nurses, physician assistants, and other medical professionals will not have to be disclosed
  • The information will be displayed in an online government database that you will be able to search

In the meantime, you can search ProPublica’s database to see the disclosed payments made to physicians in your state. Many of the most prestigious universities, including Harvard, are now banning their staff from receiving money from drug companies for speaking, and this new disclosure requirement will hopefully push more institutions in that direction.

Breaking the drug industry’s stranglehold on the conventional medical industry will not be easy — after all, the drug industry spends nearly twice as much on promotion as it does on research and development — but the tide is beginning to turn. Increasing numbers of people are now waking up to these harsh realities, and you, being among those who are informed, can help share this knowledge with others. More than 1.5 million people receive this newsletter, and together, we can make a huge difference.

The ultimate goal is to have a critical mass of people refuse the unnecessarily dangerous and counterproductive solutions currently offered by conventional medicine, as this will be the powerful stimulus to generate authentic change. You can also act now, on a personal level, by making the necessary lifestyle changes that will allow you to take control of your health, instead of leaving it in the hands of the drug industry.

Read the full article here: http://articles.mercola.com/sites/articles/archive/2014/01/08/glaxosmithkline-drug-promotion.aspx

Confessions 20of 20an 20Rx 20Drug 20Pusher Glaxo to Stop Paying Doctors for Drug Promotion

Free Shipping Available for this book!
Learn More


0 commentsback to post

Other articlesgo to homepage

CDC Autism Scandal: Tsunami of Anger is Brewing and About to Explode

CDC Autism Scandal: Tsunami of Anger is Brewing and About to Explode

Pin It

I don’t know if the fact that CNN is headquartered in Atlanta, the same city where the CDC has its headquarters, has anything to do with it, but an editorial decision was made by someone at CNN to embed a video at the top of their report on the CDC whistleblower from earlier in 2014 where health correspondent Elizabeth Cohen states that within all of the dangerous side-effects of vaccines, autism is not listed. She then rephrased for those needing help understanding her, explaining that “Some people don’t hear this well: vaccines do not cause autism.”

This editorial decision to include this video by CNN, could go down as one of the biggest blunders by a major news network of all time.

The result has been that thousands of families who have children that have been damaged by vaccines that resulted in autism, have begun to post videos on the Autism Media YouTube channel on a page called: “Hear this Well: Breaking the Silence on Vaccine Violence.”

As you watch the anger and heartache in the videos posted in response to CNN’s Elizabeth Cohen’s remarks, be aware that this is just the beginning. This pent up sentiment based on real experiences is currently a tidal wave that is quickly becoming a tsunami. The mainstream media has no idea what they are up against yet.

Former Staff Lead on Original Congressional Investigation Looking at Vaccine Injuries Speaks Out on CDC Fraud

Former Staff Lead on Original Congressional Investigation Looking at Vaccine Injuries Speaks Out on CDC Fraud

Pin It

Beth Clay was the staff lead on the original House Oversight Committee’s investigation looking into concerns about vaccine injuries in 1999. Working in Congress, she had a genuine desire to find the truth and find solutions regarding the rapidly increasing autism rates. What she found during her time in Congress, however, shocked her. So the recent revelations of Dr. Thompson, the CDC whistleblower, are not really “news” to her. Sadly, a government agency withholding information about a link between vaccines and autism is representative of the kind of fraud she too observed during her years in Congress.

CDC Director of Immunization Safety Admits Bias and Withholding Data Linking Vaccines to Autism

CDC Director of Immunization Safety Admits Bias and Withholding Data Linking Vaccines to Autism

Pin It

In what is quickly becoming one of the largest news stories in our lifetime, things are just getting worse for the CDC and their cover-up of data linking vaccines to autism.

Investigative journalist Sharyl Attkisson has posted a recorded phone call she just had with Dr. Frank DeStefano, the CDC Director of Immunization Safety. Dr. DeStefano was a co-author with CDC whistleblower Dr. William Thompson on a 2004 study that originally was put forward as research showing there was no link between vaccines and autism. Dr. Thompson has come forward and revealed that data was withheld from the public that showed an increased risk of autism in certain populations, specifically African American boys. The CDC has already made a public announcement admitting that they did withhold some data.

Dr. DeStefano has publicly stated that while he will reveal the data again, but that he is standing by the original study. A new audio recording of a conversation he just had with independent investigative reporter Sharyl Attkisson has just been posted on the Internet.

In this interview, Dr. DeStefano, who is not a whistle-blower, has come out with his own confession of bias and way of interpreting data so that it does not have to be shared with the public if it is not favorable with what they want to communicate regarding vaccines.

Dr. DeSefano and the CDC is being forced to answer questions like this (which unfortunately the mainstream media as of yet are NOT asking) because his co-author on the study, Dr. William Thompson, has hired one of the top whistleblower attorney’s in the nation so that he can come forward and reveal all the data the CDC has been hiding in regards to vaccines and autism.

60+ Natural ALS Cures the “Ice Washing” Campaign Isn’t Funding!

60+ Natural ALS Cures the “Ice Washing” Campaign Isn’t Funding!

Pin It

In a previous article we published on where funds donated to the ALS Association are being spent, we showed that a small percentage was actually spent on research, and even then only on pharmaceutical products. This has been our most popular story of the year so far.

Sayer Ji brings us a great review of over 60 natural cures that have published research on helping ALS. He also shows how some of the corporate sponsors of the ALS Association are pharmaceutical companies producing drugs that are linked to the cause of ALS!

MSM Marginalizes CDC Whistleblower Story on Vaccine-Autism Coverup

MSM Marginalizes CDC Whistleblower Story on Vaccine-Autism Coverup

Pin It

CNN was the first mainstream media (MSM) outlet to publish a story on the CDC whistleblower story linking vaccines to autism. Predictably, CNN marginalized this story on their website, and then posted a video from their TV network which said nothing about the CDC whistleblower Dr. William Thompson, but simply reiterated the MSM’s belief that all vaccines are safe and do not cause autism. They have posted a video that incorrectly represents facts regarding infant mortality and current whooping cough outbreaks that are occurring among fully vaccinated populations.

How can we trust anything CNN says on the vaccine issue if they misrepresent such basic facts regarding vaccines that are easily verified by 3rd party sources?

This story regarding the CDC cover-up has become too big for the MSM to ignore. They have to address it, but predictably they will continue to cover the story from their own belief system that the vaccine-autism debate is over, and that only one side of the debate should be heard. For those reporters that would dare to cover both sides of the debate, they will soon be without a career in MSM. So perhaps the American public needs to wake up and acknowledge this fact, and research the issue for themselves. A current senior scientist working for the CDC who has regrets over his participation in covering up data linking vaccines to autism is something worth taking some time to research.

read more


Get the news right in your inbox!